Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 3
1983 1
1984 1
1985 6
1986 1
1987 2
1988 7
1989 8
1990 5
1991 8
1992 11
1993 8
1994 13
1995 6
1996 4
1997 6
1998 3
1999 4
2000 8
2001 5
2002 6
2003 7
2004 8
2005 14
2006 5
2007 5
2008 6
2009 8
2010 7
2011 7
2012 6
2013 3
2014 21
2015 24
2016 6
2017 8
2018 6
2019 8
2020 10
2021 5
2022 9
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Results by year

Filters applied: . Clear all
Page 1
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.
Peters S, Pujol JL, Dafni U, Dómine M, Popat S, Reck M, Andrade J, Becker A, Moro-Sibilot D, Curioni-Fontecedro A, Molinier O, Nackaerts K, Insa Mollá A, Gervais R, López Vivanco G, Madelaine J, Mazieres J, Faehling M, Griesinger F, Majem M, González Larriba JL, Provencio Pulla M, Vervita K, Roschitzki-Voser H, Ruepp B, Mitchell P, Stahel RA, Le Pechoux C, De Ruysscher D; ETOP/IFCT 4-12 STIMULI Collaborators. Peters S, et al. Among authors: stahel ra. Ann Oncol. 2022 Jan;33(1):67-79. doi: 10.1016/j.annonc.2021.09.011. Epub 2021 Sep 23. Ann Oncol. 2022. PMID: 34562610 Free article. Clinical Trial.
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial.
Munzone E, Regan MM, Cinieri S, Montagna E, Orlando L, Shi R, Campadelli E, Gianni L, Palleschi M, Petrelli F, Bengala C, Generali D, Collovà E, Puglisi F, Cretella E, Zamagni C, Chini C, Ruepp B, Loi S, Colleoni M; International Breast Cancer Study Group (IBCSG). Munzone E, et al. JAMA Oncol. 2023 Sep 1;9(9):1267-1272. doi: 10.1001/jamaoncol.2023.2150. JAMA Oncol. 2023. PMID: 37440239 Clinical Trial.
Obere Einflussstauung - Vena-cava-superior-Syndrom.
Nater H, Niggemeier V, Stahel RA, Franzen D. Nater H, et al. Among authors: stahel ra. Praxis (Bern 1994). 2013 Apr 15;102(9):503-12. doi: 10.1024/1661-8157/a001306. Praxis (Bern 1994). 2013. PMID: 23608409 Free article. German. No abstract available.
Biology of lung cancer.
Stahel RA. Stahel RA. Lung Cancer. 1994 Mar;10 Suppl 1:S59-65. doi: 10.1016/0169-5002(94)91667-5. Lung Cancer. 1994. PMID: 8087528 Review.
Searching for targets for the systemic therapy of mesothelioma.
Stahel RA, Weder W, Felley-Bosco E, Petrausch U, Curioni-Fontecedro A, Schmitt-Opitz I, Peters S. Stahel RA, et al. Ann Oncol. 2015 Aug;26(8):1649-60. doi: 10.1093/annonc/mdv101. Epub 2015 Feb 26. Ann Oncol. 2015. PMID: 25722383 Free article. Review.
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.
Soo RA, Han JY, Dafni U, Cho BC, Yeo CM, Nadal E, Carcereny E, de Castro J, Sala MA, Bernabé R, Coate L, Provencio Pulla M, Garcia Campelo R, Cuffe S, Hashemi SMS, Früh M, Massuti B, Garcia-Sanchez J, Dómine M, Majem M, Sanchez-Torres JM, Britschgi C, Pless M, Dimopoulou G, Roschitzki-Voser H, Ruepp B, Rosell R, Stahel RA, Peters S; ETOP 10-16 BOOSTER Collaborators. Soo RA, et al. Among authors: stahel ra. Ann Oncol. 2022 Feb;33(2):181-192. doi: 10.1016/j.annonc.2021.11.010. Epub 2021 Nov 26. Ann Oncol. 2022. PMID: 34839016 Free article. Clinical Trial.
Successful publishing: how to get your paper accepted.
Audisio RA, Stahel RA, Aapro MS, Costa A, Pandey M, Pavlidis N. Audisio RA, et al. Among authors: stahel ra. Surg Oncol. 2009 Dec;18(4):350-6. doi: 10.1016/j.suronc.2008.09.001. Epub 2008 Oct 11. Surg Oncol. 2009. PMID: 18849161 Review.
270 results